US Codex
C.F.R.
Browse by date
Notes

§524.1484f. Neomycin, prednisolone, and tetracaine otic suspension.

21 C.F.R. § 524.1484f

(a)
Specifications. The product contains 5 milligrams of neomycin sulfate equivalent to 3.5 milligrams of neomycin base, 2.5 milligrams of prednisolone acetate, and 5 milligrams of tetracaine hydrochloride in each milliliter of sterile suspension.
(b)
Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c)
Conditions of use in dogs and cats—
(1)
Amount. Instill 2 to 6 drops in the external ear canal 2 or 3 times daily.
(2)
Indications for use. For the treatment of acute otitis externa and, to a lesser degree, chronic otitis externa; as treatment or adjunctive therapy of certain ear conditions caused by or associated with neomycin-susceptible organisms and/or allergy.
(3)
Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Notes, amendments, and revision history

Amendments

[40 FR 13873, Mar. 27, 1975, as amended at 79 FR 10971, Feb. 27, 2014]

Authority

Authority: 21 U.S.C. 360b.

Source

Source: 40 FR 13873, Mar. 27, 1975, unless otherwise noted.

Amendments

[40 FR 13873, Mar. 27, 1975, as amended at 79 FR 10971, Feb. 27, 2014]